rethinkTHC Search
Menu
Study breakdown

Cannabinoids Show Promise for Atopic Dermatitis Through Multiple Anti-Inflammatory Pathways

ReviewPreliminary evidence
The takeaway

A review found cannabinoids may complement existing atopic dermatitis treatments by targeting skin barrier function, itching, and inflammation through the endocannabinoid system.

dermatologists, eczema patients, topical cannabinoid formulators

What the researchers found

Cannabinoids interact with the endocannabinoid system in skin to potentially address multiple aspects of atopic dermatitis: skin barrier repair, anti-inflammatory effects, and itch reduction. The review assesses their potential as complementary topical treatments alongside existing therapies.

Why it matters

Atopic dermatitis affects millions worldwide and current treatments have limitations. Cannabinoids represent a novel therapeutic approach that targets multiple disease mechanisms simultaneously through the skin's endocannabinoid system.

The numbers in context

AD characterized by: skin barrier loss, itching, xerosis, inflammation. Cannabinoids target: barrier function, inflammation, itch signaling. ECS components present in skin tissue.

How the study worked

Review of the therapeutic potential of cannabinoids for atopic dermatitis, covering mechanisms of action through the skin's endocannabinoid system and available evidence from preclinical and clinical studies.

What this study cannot tell us

Review level evidence only. Limited clinical trial data for AD specifically. Most evidence is preclinical. Dosing and formulation for topical skin application not standardized.

How to read the evidence

Review of predominantly preclinical evidence with limited clinical data provides preliminary evidence.

When this study was published

Contemporary review of cannabinoids for atopic dermatitis.

The bigger picture

While the rationale for cannabinoid use in AD is biologically sound, clinical evidence remains limited. The convergence of endocannabinoid science and dermatology is still in early stages.

Questions still open

  • Which cannabinoid formulations are most effective for topical skin application?
  • Could cannabinoid creams replace steroid treatments for AD?

Common questions

Can cannabis cream help eczema?
The biological rationale is promising: cannabinoids interact with the skin's endocannabinoid system to potentially reduce inflammation and itching. However, rigorous clinical trials are still needed.
Would cannabinoid treatment replace current eczema medications?
The review positions cannabinoids as complementary treatments alongside existing therapies, not replacements. More research is needed before any clinical recommendations can be made.

Read the original research

Therapeutic potential of cannabinoids for treating atopic dermatitis.

Journal of cannabis research, 7(1), 57

Citation

Stoco, Adriel Aparecido Geraldo; Mazzola, Priscila Gava. (2025). Therapeutic potential of cannabinoids for treating atopic dermatitis.. Journal of cannabis research, 7(1), 57. https://doi.org/10.1186/s42238-025-00317-4

Explore the wider topic